Cargando…

Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation

The number of publications studying the therapeutic use of stem cells has steadily increased since 2000. Compared to other applications, there has been little interest in the evaluation of mesenchymal stem cells (MSCs) and MSC-derived products (mostly extracellular vesicles) for the treatment of res...

Descripción completa

Detalles Bibliográficos
Autor principal:	Fröhlich, Eleonore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915745/ https://www.ncbi.nlm.nih.gov/pubmed/33562240 http://dx.doi.org/10.3390/pharmaceutics13020232

Ejemplares similares

Measurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled Compounds
por: Fröhlich, Eleonore, et al.
Publicado: (2016)

Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations
por: Fröhlich, Eleonore
Publicado: (2019)

Editorial: Advances in orally inhaled and nasal drug products (OINDPs)
por: Mehta, Piyush Pradeep, et al.
Publicado: (2023)

Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening
por: Fröhlich, Eleonore
Publicado: (2017)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, ex Vivo, in Vitro, and in Silico Studies
por: Fröhlich, Eleonore, et al.
Publicado: (2014)

The effect of intravenous labetalol administration on hemodynamic responses during desflurane inhalation
por: Do, Hyun-Seok, et al.
Publicado: (2012)

Screening for Effects of Inhaled Nanoparticles in Cell Culture Models for Prolonged Exposure
por: Meindl, Claudia, et al.
Publicado: (2021)

Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease
por: Mohammadipoor, Arezoo, et al.
Publicado: (2018)

The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
por: Guo, Yajun, et al.
Publicado: (2020)

Prevention of glucocorticoid-associated osteonecrosis by intravenous administration of mesenchymal stem cells in a rabbit model
por: Ueda, Shusuke, et al.
Publicado: (2017)

Optimal Intravenous Administration Procedure for Efficient Delivery of Canine Adipose-Derived Mesenchymal Stem Cells
por: Yasumura, Yuyo, et al.
Publicado: (2022)

Developing inhaled protein therapeutics for lung diseases
por: Matthews, Abigail A., et al.
Publicado: (2020)

Intravenous Administration of Human Umbilical Cord Mesenchymal Stromal Cells Leads to an Inflammatory Response in the Lung
por: Hernandez Pichardo, Alejandra, et al.
Publicado: (2023)

Double‐edged sword of mesenchymal stem cells: Cancer‐promoting versus therapeutic potential
por: Lee, Hwa‐Yong, et al.
Publicado: (2017)

Mesenchymal stem cells as potential therapeutic approaches in celiac disease
por: Moheb-Alian, Ali, et al.
Publicado: (2016)

Mesenchymal Stromal/Stem Cells and Their Products as a Therapeutic Tool to Advance Lung Transplantation
por: Miceli, Vitale, et al.
Publicado: (2022)

Inhalational versus intravenous anesthetics during one lung ventilation in elective thoracic surgeries: A narrative review
por: Parab, Swapnil, et al.
Publicado: (2021)

Mesenchymal stem cells in radiation-induced lung injury: From mechanisms to therapeutic potential
por: Hou, Guowen, et al.
Publicado: (2022)

Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1α
por: Wang, Feifei, et al.
Publicado: (2010)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases
por: Mannino, Giuliana, et al.
Publicado: (2021)

Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis
por: Choi, Sun Mi, et al.
Publicado: (2023)

Intravenous administration of puppy deciduous teeth stem cells in degenerative valve disease
por: Petchdee, Soontaree, et al.
Publicado: (2016)

Total versus inhaled intravenous anesthesia methods for prognosis of patients with lung, breast, or esophageal cancer: A cohort study
por: Che, Xiangming, et al.
Publicado: (2023)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
por: Epstein, Robert S
Publicado: (2021)

Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine
por: Patel, Devang M., et al.
Publicado: (2013)

Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis
por: Li, Feifei, et al.
Publicado: (2017)

Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
por: Hmadcha, Abdelkrim, et al.
Publicado: (2020)

The therapeutic potential of mesenchymal stem cells in treating osteoporosis
por: Chen, Tianning, et al.
Publicado: (2021)

Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells
por: Yang, Guoqiang, et al.
Publicado: (2023)

The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential
por: Slama, Youssef, et al.
Publicado: (2023)

Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
por: Yang, Sirui, et al.
Publicado: (2013)

Intravenous administration of anti-inflammatory mesenchymal stem cell spheroids reduces chronic alcohol intake and abolishes binge-drinking
por: Ezquer, Fernando, et al.
Publicado: (2018)

Dose-Dependent Effect of Intravenous Administration of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Neonatal Stroke Mice
por: Tanaka, Emi, et al.
Publicado: (2018)

Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
por: Eggenhofer, E., et al.
Publicado: (2012)

Therapeutic Potential of Human Mesenchymal Stem Cells for Treating Ischemic Limb Diseases
por: Han, Kyu-Hyun, et al.
Publicado: (2016)

Strategies to Potentiate Paracrine Therapeutic Efficacy of Mesenchymal Stem Cells in Inflammatory Diseases
por: Seo, Yoojin, et al.
Publicado: (2021)

Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases
por: Wang, Yu, et al.
Publicado: (2020)

Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases
por: Hua, Chunting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fism4009eq2ums2017jvo0r1t9